Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Moderna Therapeutics
Moderna Therapeutics
Activities:
Research & Development
Cardiovascular
Digestion
Pharmaceutical
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
CleanLock Module: AES Clean Technology launches new cleanroom airlock
The cleanroom provider has launched its new airlock, which offers a secure transition for people and materials entering and exiting cleanroom environments
New material captures coronavirus particles to boost face mask efficiency
Researchers at the University of Liverpool have looked to significantly boost face mask efficiency by developing a new material that captures coronavirus particles
Cell therapy innovation: Germfree and Orgenesis enter strategic partnership
Germfree and Orgenesis have announced an asset purchase and strategic partnership aimed at advancing Orgenesis’ therapeutic programmes, its suite of product development and...
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Design & Build
Albian Group celebrates milestone in important Moderna project outside the US
Moderna has inaugurated its first laboratory outside of the US for quality trials of its messenger RNA vaccines, for which Albian Group provided several services
Design & Build
Glencar wins new UK Moderna vaccine manufacturing hub contract
Glencar has been chosen by Harwell Campus to build the new facility and will work with Merit on controlled environment aspects
Regulatory
Moderna reveals findings of vaccine contamination event
A rare presence of Grade 316 stainless steel particles in the vaccine vials has been found but does not pose an undue risk to patient safety
Finance
Azzur Group and Moderna expand six-year cleanroom relationship
As part of the expanded relationship, Moderna will become the anchor client in Azzur's most recent COD facility in Burlington, Massachusetts
Manufacturing
Recipharm to manufacture Moderna COVID-19 vaccine
The CDMO will carry out aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273)
Research & Development
Coronavirus: Frontrunners approach end of Phase III trials
Pfizer and BioNTech have recently revealed promising data showing their vaccine candidate is 90% effective
Design & Build
ISPE names Facility of the Year 2019
Six winners in seven categories recognising innovation and creativity in manufacturing facilities serving the regulated healthcare industry
Subscribe now